Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
International Journal of Toxicology|June 17, 2021
Nonclinical Safety Profile of Sotorasib, a KRASG12C-Specific Covalent Inhibitor for the Treatment of KRAS p.G12C-Mutated CancerKatsu Ishida, Jonathan A Werner, Rhian Davies, et al.
Clinical and Translational Science|November 12, 2022
Evaluation of levocetirizine in beagle dog and cynomolgus monkey telemetry assays: Defining the no QTc effect profile by timepoint and concentration-QTc analysisMichael J Engwall, Joel Baublits, Fiona A Chandra, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
Allergen-specific MHC class II tetramer+ cells are detectable in allergic, but not in nonallergic, individualsClaudia Macaubas, Jan Wahlstrom, Ana Paula Galvão da Silva, et al.
Biochemical and Biophysical Research Communications|June 24, 2026
Rapid screening approaches to identify and confirm lysosomotropic agents among ECCS class 2 basic drugsOsatohanmwen J Enogieru, Minhkhoi Nguyen, Ling Zou, et al.
Journal of Pharmaceutical Sciences|February 3, 2015
Utilizing physiologically based pharmacokinetic modeling to inform formulation and clinical development for a compound with pH-dependent solubilityJohn Chung, Fernando Alvarez-Nunez, Vincent Chow, et al.
Toxicology and Applied Pharmacology|May 18, 2021
Mercapturate pathway metabolites of sotorasib, a covalent inhibitor of KRASG12C, are associated with renal toxicity in the Sprague Dawley ratJonathan A Werner, Rhian Davies, Jan Wahlstrom, et al.
Regenerative Medicine|May 19, 2012
Disclosure and management of research findings in stem cell research and banking: policy statementRosario Isasi, Bartha M Knoppers, Peter W Andrews, et al.
Pageof 3